Skip to main content
281 search results for:

Glucagon 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 17-03-2022 | Glucagon | News | Article

    Mini-dose glucagon better than glucose tablets for Ramadan hypoglycemia

    Subcutaneous mini-dose glucagon reverses hypoglycemia more effectively than oral glucose tablets and helps adults with type 1 diabetes complete Ramadan fasts, shows a randomized crossover trial.

  2. 04-05-2018 | GLP-1 agonists | Review | Article

    Glucagon-like peptide 1 in health and disease

    In healthy individuals, the incretin hormone glucagon-like peptide 1 (GLP1) potentiates insulin release and suppresses glucagon secretion in response

  3. 25-05-2018 | Hypoglycemia | News | Article

    Mini-dose glucagon could help protect against exercise-induced hypoglycemia

    Modestly increasing glucagon levels when commencing physical activity could be an effective strategy for preventing exercise-induced hypoglycemia among patients with type 1 diabetes, results of a randomized crossover trial suggest.

  4. 16-05-2018 | Artificial pancreas systems | News | Article

    Glucagon in closed-loop system guards against exercise-induced hypoglycemia

    And in the dual-hormone system, exercise confirmation also resulted in the target glucose for glucagon being raised from 95 to 120 mg/dL and the maximum glucagon dose doubled.

  5. 22-08-2018 | Retinopathy | Article

    Glucagon-like peptide-1 receptor agonists and the risk of incident diabetic retinopathy

    Douros A et al. Diabetes Care 2018: dc172280. doi: 10.2337/dc17-2280

  6. 03-01-2018 | Glucagon | News | Article

    Glucagon use restrictions compromising prehospital hypoglycemia treatment in USA

    The widespread bar on glucagon administration by basic providers of emergency medicine in the USA may prevent its use in three-quarters of cases in which it is needed, say researchers.

  7. 24-03-2018 | GLP-1 agonists | Review | Article

    Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification

    Trautmann ME, Vora J.  Diabet Med 2018; Advance online publication. doi: 10.1111/dme.13610

  8. 17-07-2018 | Heart failure | Article

    Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

    The authors assess the risk of hospitalization due to HF with the use of dipeptidyl peptidase-4 inhibitors compared to glucagon like peptide-1

  9. 23-10-2017 | Cardiovascular disorders | Editorial | Article

    Diabetes in special situations: Glucagon-like peptide-1 receptor agonist use in acute myocardial infarction

    Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of glucagon-like peptide-1 receptor agonists in patients affected by acute myocardial infarction.

  10. 04-05-2018 | SGLT2 inhibitors | Review | Article

    Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes

    A systematic review and meta-analysis

    Zheng et al. JAMA  2018; 319:1580. doi: 10.1001/jama.2018.3024

  11. 16-02-2017 | Type 2 diabetes | In practice | Article

    The role of the pharmacist in managing type 2 diabetes with glucagon-like peptide-1 receptor agonists as add-on therapy

    Meece J. Adv Ther 2017; 34: 638–657. doi: 10.1007/s12325-017-0491-1

  12. 30-09-2016 | SGLT2 inhibitors | Article

    Combination therapy with glucagon-like peptide-1 analogues and sodium-glucose cotransporter-2 inhibitors in the management of diabesity: the real world experience

    Deol H et al. Endocrine 2017; 55: 173–178. doi: 10.1007/s12020-016-1125-0

  13. 11-05-2016 | Heart failure | Article

    Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: Systematic review and meta-analysis of randomized and observational studies

    This article presents the results of a meta-analysis of 25 eligible studies of glucagon-like peptide 1 agonists, conducted to assess their effects on

  14. 20-04-2015 | Dapagliflozin | ReviewPaper | Article

    Inhibition of the glucose transporter sodium-glucose cotransporter-2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

    Plasma glucagon levels were measured using the Glucagon Quantikine ELISA Kit (R & D Systems Europe, Lille CEDEX, France) according to the manufacturer's instructions.

  15. 07-05-2021 | Glucagon | News | Article

    Dasiglucagon promising for severe hypoglycemia in children with type 1 diabetes

    Dasiglucagon, a next-generation glucagon analog in a ready-to-use formulation, rapidly restores plasma glucose levels following severe hypoglycemia in children and adolescents with type 1 diabetes, show findings from a phase 3 trial.

  16. 11-06-2019 | Glucagon | News | Article

    Phase III data support dasiglucagon use for severe hypoglycemia

    . © 2019 Springer Healthcare part of the Springer Nature group 79th ADA Scientific Sessions; San Francisco, California, USA: 7–11 June 2019 More on this topic News story | Glucagon use restrictions compromising prehospital hypoglycemia treatment in USA ​​​​​​​

  17. 08-02-2023 | Heart failure | News | Article

    Meta-analysis shows mixed picture for GLP-1 receptor agonists in heart failure

    A meta-analysis suggests that glucagon-like peptide-1 receptor agonists may help prevent new-onset heart failure in people with type 2 diabetes.

  18. 28-06-2017 | Topic page

    Glucagon-like peptide-1 agonists

  19. 20-07-2023 | Type 2 diabetes | News | Article

    Triple agonist shows promise for both glycemic and weight control

    The findings, which were simultaneously presented at the 83rd ADA Scientific Sessions in San Diego, California, USA, confirm those of the 12-week phase 1 study and “support phase 3 clinical development” of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide (GLP)-1, and glucagon receptor agonist, the researchers comment.

  20. 26-05-2022 | Insulin glargine | News | Article
    News in brief

    Real-world support for adding Gla-300 to GLP-1 receptor agonists in type 2 diabetes

    The addition of insulin glargine 300 units/mL to glucagon-like peptide-1 receptor agonist therapy in people with type 2 diabetes results in improved glycemic control without increasing risk for hypoglycemia, suggest findings from the real-world DELIVER-G study.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.